Interactome Bio ('IB' or the 'Company'), a growing biotechnology organization, announced titles of 2 abstracts to be presented as oral presentations at the National Cancer Institutes Comprehensive Cancer Center Meeting on Solving Critical Problems in Cancer Control using Spatial Science on Jan. 18 to Jan. 19, 2023 in Los Angeles, California at the University of Southern California Norris Comprehensive Cancer Center.
Read more at interactomebio.com.